Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Stephen Hearty, Paul J Conroy, B Vijayalakshmi Ayyar, Barry Byrne & Richard O’Kennedy. (2010) Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends. Expert Review of Vaccines 9:6, pages 645-664.
Read now
Read now
Articles from other publishers (77)
Anna Timofeeva, Sergey Sedykh & Georgy Nevinsky. (2022) Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities. Vaccines 10:3, pages 384.
Crossref
Crossref
Eunice W. Nduati, Mathew J. Gorman, Yiakon Sein, Tandile Hermanus, Dansu Yuan, Ian Oyaro, Daniel M. Muema, Thumbi Ndung’u, Galit Alter & Penny L. Moore. (2021) Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination. AIDS 35:12, pages 1895-1905.
Crossref
Crossref
Jingfu Zhao, Ehwang Song, Yifan Huang, Aiying Yu & Yehia Mechref. (2021) Variability in the Glycosylation Patterns of gp120 Proteins from Different Human Immunodeficiency Virus Type 1 Isolates Expressed in Different Host Cells. Journal of Proteome Research 20:10, pages 4862-4874.
Crossref
Crossref
Zhujun Ao, Lijun Wang, Hiva Azizi, Titus Abiola Olukitibi, Gary Kobinger & Xiaojian Yao. (2021) Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1. Journal of Virology 95:15.
Crossref
Crossref
Egidio Brocca-Cofano, David Kuhrt, Basile Siewe, Cuiling Xu, George S. Haret-Richter, Jodi Craigo, Celia Labranche, David C. Montefiori, Alan Landay, Cristian Apetrei & Ivona Pandrea. (2017) Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction. Journal of Virology 91:23.
Crossref
Crossref
Muzamil Ashraf Makhdoomi, Deepti Singh, Ambili Nair Pananghat, Rakesh Lodha, Sushil Kumar Kabra & Kalpana Luthra. (2016) Neutralization resistant HIV-1 primary isolates from antiretroviral naïve chronically infected children in India. Virology 499, pages 105-113.
Crossref
Crossref
Yan-Mei Huang, Xue-Zhi Hong, Jia-Hua Xu, Jiang-Xi Luo, Han-You Mo & Hai-Lu Zhao. (2015) Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome. Immunologic Research 64:3, pages 641-652.
Crossref
Crossref
Brodie Miles, Shannon M. Miller, Joy M. Folkvord, Abigail Kimball, Mastooreh Chamanian, Amie L. Meditz, Tessa Arends, Martin D. McCarter, David N. Levy, Eva G. Rakasz, Pamela J. Skinner & Elizabeth Connick. (2015) Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nature Communications 6:1.
Crossref
Crossref
Yali Qin, Saikat Banerjee, Aditi Agrawal, Heliang Shi, Marisa Banasik, Feng Lin, Kari Rohl, Celia LaBranche, David C. Montefiori & Michael W. Cho. (2015) Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop. PLOS ONE 10:6, pages e0128823.
Crossref
Crossref
Kevin O. Saunders, Amarendra Pegu, Ivelin S. Georgiev, Ming Zeng, M. Gordon Joyce, Zhi-Yong Yang, Sung-Youl Ko, Xuejun Chen, Stephen D. Schmidt, Ashley T. Haase, John-Paul Todd, Saran Bao, Peter D. Kwong, Srinivas S. Rao, John R. Mascola & Gary J. Nabel. (2015) Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection. Journal of Virology 89:11, pages 5895-5903.
Crossref
Crossref
Sandra García-Gallego, Laura Díaz, José Luis Jiménez, Rafael Gómez, F. Javier de la Mata & M. Ángeles Muñoz-Fernández. (2015) HIV-1 antiviral behavior of anionic PPI metallo-dendrimers with EDA core. European Journal of Medicinal Chemistry 98, pages 139-148.
Crossref
Crossref
Kristen Cohen, Marcus Altfeld, Galit Alter & Leonidas Stamatatos. (2014)
Early Preservation of CXCR5
+
PD-1
+
Helper T Cells and B Cell Activation Predict the Breadth of Neutralizing Antibody Responses in Chronic HIV-1 Infection
. Journal of Virology 88:22, pages 13310-13321.
Crossref
Crossref
Tim-Henrik Bruun, Katharina M?hlbauer, Thomas Benen, Alexander Kliche & Ralf Wagner. (2014) A Mammalian Cell Based FACS-Panning Platform for the Selection of HIV-1 Envelopes for Vaccine Development. PLoS ONE 9:10, pages e109196.
Crossref
Crossref
Yali Qin, Marisa Banasik, SoonJeung Kim, Adam Penn-Nicholson, Habtom H Habte, Celia LaBranche, David C Montefiori, Chong Wang & Michael W Cho. (2014) Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence. Virology 462-463, pages 363-376.
Crossref
Crossref
G.M. Air & J.T. West. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Daniel J Stieh, Joshua L Phillips, Paul M Rogers, Deborah F King, Gianguido C Cianci, Simon A Jeffs, Sandrasegaram Gnanakaran & Robin J Shattock. (2013) Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein. Retrovirology 10:1.
Crossref
Crossref
Guohua Yi, Mauro Lapelosa, Rachel Bradley, Thomas M. Mariano, Denise Elsasser Dietz, Scott Hughes, Terri Wrin, Chris Petropoulos, Emilio Gallicchio, Ronald M. Levy, Eddy Arnold & Gail Ferstandig Arnold. (2013) Chimeric Rhinoviruses Displaying MPER Epitopes Elicit Anti-HIV Neutralizing Responses. PLoS ONE 8:9, pages e72205.
Crossref
Crossref
Yao Chen, Jinsong Zhang, Kwan-Ki Hwang, Hilary Bouton-Verville, Shi-Mao Xia, Amanda Newman, Ying-Bin Ouyang, Barton F. Haynes & Laurent Verkoczy. (2013) Common Tolerance Mechanisms, but Distinct Cross-Reactivities Associated with gp41 and Lipids, Limit Production of HIV-1 Broad Neutralizing Antibodies 2F5 and 4E10. The Journal of Immunology 191:3, pages 1260-1275.
Crossref
Crossref
Rajesh Ringe & Jayanta Bhattacharya. (2013) Preventive and therapeutic applications of neutralizing antibodies to Human Immunodeficiency Virus Type 1 (HIV-1). Therapeutic Advances in Vaccines 1:2, pages 67-80.
Crossref
Crossref
John R. Mascola & Barton F. Haynes. (2013) HIV-1 neutralizing antibodies: understanding nature's pathways. Immunological Reviews 254:1, pages 225-244.
Crossref
Crossref
Guang Yang, T. Matt Holl, Yang Liu, Yi Li, Xiaozhi Lu, Nathan I. Nicely, Thomas B. Kepler, S. Munir Alam, Hua-Xin Liao, Derek W. Cain, Leonard Spicer, John L. VandeBerg, Barton F. Haynes & Garnett Kelsoe. (2013) Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. Journal of Experimental Medicine 210:2, pages 241-256.
Crossref
Crossref
F. Benjelloun, P. Lawrence, B. Verrier, C. Genin & S. Paul. (2012) Role of Human Immunodeficiency Virus Type 1 Envelope Structure in the Induction of Broadly Neutralizing Antibodies. Journal of Virology 86:24, pages 13152-13163.
Crossref
Crossref
Peter D Kwong, John R Mascola & Gary J Nabel. (2012) The changing face of HIV vaccine research. Journal of the International AIDS Society 15:2.
Crossref
Crossref
Rajesh Ringe & Jayanta Bhattacharya. (2012) Association of Enhanced HIV-1 Neutralization by a Single Y681H Substitution in gp41 with Increased gp120-CD4 Interaction and Macrophage Infectivity. PLoS ONE 7:5, pages e37157.
Crossref
Crossref
Gary J. Nabel, Peter D. Kwong & John R. Mascola. (2011) Progress in the rational design of an AIDS vaccine. Philosophical Transactions of the Royal Society B: Biological Sciences 366:1579, pages 2759-2765.
Crossref
Crossref
B. K. Chakrabarti, L. M. Walker, J. F. Guenaga, A. Ghobbeh, P. Poignard, D. R. Burton & R. T. Wyatt. (2011) Direct Antibody Access to the HIV-1 Membrane-Proximal External Region Positively Correlates with Neutralization Sensitivity. Journal of Virology 85:16, pages 8217-8226.
Crossref
Crossref
Bimal K. ChakrabartiMarie PanceraSanjay PhogatSijy O'DellKrisha McKeeJavier GuenagaJames RobinsonJohn MascolaRichard T. Wyatt. (2011) HIV Type 1 Env Precursor Cleavage State Affects Recognition by Both Neutralizing and Nonneutralizing gp41 Antibodies. AIDS Research and Human Retroviruses 27:8, pages 877-887.
Crossref
Crossref
Zohar Biron-Sorek, Yide Sun, Elaine Kan, Jeanne Flandez, Michael Franti, Jeffrey Ulmer, Susan Barnett & Indresh K. Srivastava. 2011. Development of Vaccines. Development of Vaccines
305
325
.
Andreas Mörner, Marianne Jansson, Evelien M. Bunnik, Jørgen Schøller, Robert Vaughan, Yufei Wang, David C. Montefiori, Nel Otting, Ronald Bontrop, Lesley A. Bergmeier, Mahavir Singh, Richard T. Wyatt, Hanneke SchuitemakerGunnel Biberfeld, Rigmor Thorstensson & Thomas Lehner. (2011) Immunization with Recombinant HLA Classes I and II, HIV-1 gp140, and SIV p27 Elicits Protection against Heterologous SHIV Infection in Rhesus Macaques. Journal of Virology 85:13, pages 6442-6452.
Crossref
Crossref
Sean X. Du, Li Xu, Wenge Zhang, Susan Tang, Rebecca I. Boenig, Helen Chen, Ellaine B. Mariano, Michael B. Zwick, Paul W. H. I. Parren, Dennis R. Burton, Terri Wrin, Christos J. Petropoulos, John A. Ballantyne, Michael Chambers & Robert G. Whalen. (2011) A Directed Molecular Evolution Approach to Improved Immunogenicity of the HIV-1 Envelope Glycoprotein. PLoS ONE 6:6, pages e20927.
Crossref
Crossref
Elena V. Vassilieva, Bao-Zhong Wang, Andrei N. Vzorov, Li Wang, Ying-Chun Wang, Jadranka Bozja, Rui Xu & Richard W. Compans. (2011) Enhanced Mucosal Immune Responses to HIV Virus-Like Particles Containing a Membrane-Anchored Adjuvant. mBio 2:1.
Crossref
Crossref
A. Mader & R. Kunert. (2010) Humanization strategies for an anti-idiotypic antibody mimicking HIV-1 gp41. Protein Engineering Design and Selection 23:12, pages 947-954.
Crossref
Crossref
Andrew Rosa Borges, Lindsay Wieczorek, Benitra Johnson, Alan J. Benesi, Bruce K. Brown, Richard D. Kensinger, Fred C. Krebs, Brian Wigdahl, Robert Blumenthal, Anu Puri, Francine E. McCutchan, Deborah L. Birx, Victoria R. Polonis & Cara-Lynne Schengrund. (2010) Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1. Virology 408:1, pages 80-88.
Crossref
Crossref
Michael Vaine, Shixia Wang, Qin Liu, James Arthos, David Montefiori, Paul Goepfert, M. Juliana McElrath & Shan Lu. (2010) Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies. PLoS ONE 5:11, pages e13916.
Crossref
Crossref
S. Gnanakaran, Marcus G. Daniels, Tanmoy Bhattacharya, Alan S. Lapedes, Anurag Sethi, Ming Li, Haili Tang, Kelli Greene, Hongmei Gao, Barton F. Haynes, Myron S. Cohen, George M. Shaw, Michael S. Seaman, Amit Kumar, Feng Gao, David C. Montefiori & Bette Korber. (2010) Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies. PLoS Computational Biology 6:10, pages e1000955.
Crossref
Crossref
John Pietzsch, Johannes F. Scheid, Hugo Mouquet, Michael S. Seaman, Christopher C. Broder & Michel C. Nussenzweig. (2010) Anti-gp41 Antibodies Cloned from HIV-Infected Patients with Broadly Neutralizing Serologic Activity. Journal of Virology 84:10, pages 5032-5042.
Crossref
Crossref
John R. MascolaDavid C. Montefiori. (2010) The Role of Antibodies in HIV Vaccines. Annual Review of Immunology 28:1, pages 413-444.
Crossref
Crossref
Weizao Chen, Zhongyu Zhu, Huaxin Liao, Gerald V. QuinnanJr.Jr., Christopher C. Broder, Barton F. Haynes & Dimiter S. Dimitrov. (2010) Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins. Viruses 2:2, pages 547-565.
Crossref
Crossref
Michael S. Seaman, Holly Janes, Natalie Hawkins, Lauren E. Grandpre, Colleen Devoy, Ayush Giri, Rory T. Coffey, Linda Harris, Blake Wood, Marcus G. Daniels, Tanmoy Bhattacharya, Alan Lapedes, Victoria R. Polonis, Francine E. McCutchan, Peter B. Gilbert, Steve G. Self, Bette T. Korber, David C. Montefiori & John R. Mascola. (2010) Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies. Journal of Virology 84:3, pages 1439-1452.
Crossref
Crossref
Bin Yu, Dora P. A. J. Fonseca, Sara M. O'Rourke & Phillip W. Berman. (2010) Protease Cleavage Sites in HIV-1 gp120 Recognized by Antigen Processing Enzymes Are Conserved and Located at Receptor Binding Sites. Journal of Virology 84:3, pages 1513-1526.
Crossref
Crossref
Laurent Verkoczy, Marilyn Diaz, T. Matt Holl, Ying-Bin Ouyang, Hilary Bouton-Verville, S. Munir Alam, Hua-Xin Liao, Garnett Kelsoe & Barton F. Haynes. (2009) Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance. Proceedings of the National Academy of Sciences 107:1, pages 181-186.
Crossref
Crossref
Xiaodong Xiao, Weizao Chen, Yang Feng, Zhongyu Zhu, Ponraj Prabakaran, Yanping Wang, Mei-Yun Zhang, Nancy S. Longo & Dimiter S. Dimitrov. (2009) Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens. Biochemical and Biophysical Research Communications 390:3, pages 404-409.
Crossref
Crossref
K. Reed Clark & Scott T. R. Walsh. (2009) Crystal structure of a 3B3 variant-A broadly neutralizing HIV-1 scFv antibody. Protein Science 18:12, pages 2429-2441.
Crossref
Crossref
Xiaodong Xiao, Weizao Chen, Yang Feng & Dimiter S. Dimitrov. (2009) Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies. Viruses 1:3, pages 802-817.
Crossref
Crossref
Xueling Wu, Tongqing Zhou, Sijy O'Dell, Richard T. Wyatt, Peter D. Kwong & John R. Mascola. (2009) Mechanism of Human Immunodeficiency Virus Type 1 Resistance to Monoclonal Antibody b12 That Effectively Targets the Site of CD4 Attachment. Journal of Virology 83:21, pages 10892-10907.
Crossref
Crossref
Laurent Verkoczy, M. Anthony Moody, T. Matt Holl, Hilary Bouton-Verville, Richard M. Scearce, Jennifer Hutchinson, S. Munir Alam, Garnett Kelsoe & Barton F. Haynes. (2009) Functional, Non-Clonal IgMa-Restricted B Cell Receptor Interactions with the HIV-1 Envelope gp41 Membrane Proximal External Region. PLoS ONE 4:10, pages e7215.
Crossref
Crossref
John R. Mascola. (2009) The Cat and Mouse of HIV-1 Antibody Escape. PLoS Pathogens 5:9, pages e1000592.
Crossref
Crossref
Eden P. Go, Qing Chang, Hua-Xin Liao, Laura L. Sutherland, S. Munir Alam, Barton F. Haynes & Heather Desaire. (2009) Glycosylation Site-Specific Analysis of Clade C HIV-1 Envelope Proteins. Journal of Proteome Research 8:9, pages 4231-4242.
Crossref
Crossref
Bette Korber & S Gnanakaran. (2009) The implications of patterns in HIV diversity for neutralizing antibody induction and susceptibility. Current Opinion in HIV and AIDS 4:5, pages 408-417.
Crossref
Crossref
Christina Ochsenbauer & John C Kappes. (2009) New virologic reagents for neutralizing antibody assays. Current Opinion in HIV and AIDS 4:5, pages 418-425.
Crossref
Crossref
Mattia Bonsignori, M. Anthony Moody, Robert J. Parks, T. Matt Holl, Garnett Kelsoe, Charles B. Hicks, Nathan Vandergrift, Georgia D. Tomaras & Barton F. Haynes. (2009) HIV-1 Envelope Induces Memory B Cell Responses That Correlate with Plasma Antibody Levels after Envelope gp120 Protein Vaccination or HIV-1 Infection. The Journal of Immunology 183:4, pages 2708-2717.
Crossref
Crossref
Leonidas Stamatatos, Lynn Morris, Dennis R Burton & John R Mascola. (2009) Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?. Nature Medicine 15:8, pages 866-870.
Crossref
Crossref
Yun (Kenneth) Kang, Sofija Andjelic, James M. Binley, Emma T. Crooks, Michael Franti, Sai Prasad N. Iyer, Gerald P. Donovan, Antu K. Dey, Ping Zhu, Kenneth H. Roux, Robert J. Durso, Thomas F. Parsons, Paul J. Maddon, John P. Moore & William C. Olson. (2009) Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1. Vaccine 27:37, pages 5120-5132.
Crossref
Crossref
Toshio Murakami, Yasuyuki Eda, Tadashi Nakasone, Yasushi Ami, Kenji Someya, Naoto Yoshino, Masahiko Kaizu, Yasuyuki Izumi, Hajime Matsui, Katsuaki Shinohara, Naoki Yamamoto & Mitsuo Honda. (2009) Postinfection passive transfer of KD-247 protects against simian/human immunodeficiency virus-induced CD4+ T-cell loss in macaque lymphoid tissue. AIDS 23:12, pages 1485-1494.
Crossref
Crossref
Nia Tatsis, Marcio O. Lasaro, Shih-Wen Lin, Zhi Q. Xiang, Dongming Zhou, Lauren DiMenna, Hua Li, Ang Bian, Sarah Abdulla, Yan Li, Wynetta Giles-Davis, Jessica Engram, Sarah J. Ratcliffe, Guido Silvestri, Hildegund C. Ertl & Michael R. Betts. (2009) Adenovirus Vector-Induced Immune Responses in Nonhuman Primates: Responses to Prime Boost Regimens. The Journal of Immunology 182:10, pages 6587-6599.
Crossref
Crossref
Piraporn Utachee, Piyamat Jinnopat, Panasda Isarangkura-na-ayuthaya, U. Chandimal de Silva, Shota Nakamura, Uamporn Siripanyaphinyo, Nuanjun Wichukchinda, Kenzo Tokunaga, Teruo Yasunaga, Pathom Sawanpanyalert, Kazuyoshi Ikuta, Wattana Auwanit & Masanori Kameoka. (2009) Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient, residing in central Thailand. Microbes and Infection 11:3, pages 334-343.
Crossref
Crossref
Piraporn UtacheePiyamat JinnopatPanasda Isarangkura-na-ayuthayaUdayanga Chandimal de SilvaShota NakamuraUamporn SiripanyaphinyoNuanjun WichukchindaKenzo TokunagaTeruo YasunagaPathom SawanpanyalertKazuyoshi IkutaWattana AuwanitMasanori Kameoka. (2009)
Genotypic Characterization of CRF01_AE
env
Genes Derived from Human Immunodeficiency Virus Type 1-Infected Patients Residing in Central Thailand
. AIDS Research and Human Retroviruses 25:2, pages 229-236.
Crossref
Crossref
Aurelio Cafaro, Iole Macchia, Maria Teresa Maggiorella, Fausto Titti & Barbara Ensoli. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
189
242
.
Debra M. Eckert, Yu Shi, Sunghwan Kim, Brett D. Welch, Eunchai Kang, Emily S. Poff & Michael S. Kay. (2009) Characterization of the steric defense of the HIV‐1 gp41 N‐trimer region. Protein Science 17:12, pages 2091-2100.
Crossref
Crossref
INGRID LINDH, IRINA KALBINA, SARA THULIN, NIKOLAI SCHERBAK, HELENA SÄVENSTRAND, ANDREAS BRÅVE, JORMA HINKULA, ÅKE STRID & SÖREN ANDERSSON. (2008)
Feeding of mice with
Arabidopsis thaliana
expressing the HIV-1 subtype C p24 antigen gives rise to systemic immune responses
. APMIS 116:11, pages 985-994.
Crossref
Crossref
Ralph Pantophlet, Terri Wrin, Lisa A. Cavacini, James E. Robinson & Dennis R. Burton. (2008) Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity. Virology 381:2, pages 251-260.
Crossref
Crossref
Susan P Buchbinder, Devan V Mehrotra, Ann Duerr, Daniel W Fitzgerald, Robin Mogg, David Li, Peter B Gilbert, Javier R Lama, Michael Marmor, Carlos del Rio, M Juliana McElrath, Danilo R Casimiro, Keith M Gottesdiener, Jeffrey A Chodakewitz, Lawrence Corey & Michael N Robertson. (2008) Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. The Lancet 372:9653, pages 1881-1893.
Crossref
Crossref
Roberto Burioni, Nicasio Mancini, Donata De Marco, Nicola Clementi, Mario Perotti, Giovanni Nitti, Monica Sassi, Filippo Canducci, Krisha Shvela, Patrizia Bagnarelli, John R. Mascola & Massimo Clementi. (2008) Anti-HIV-1 Response Elicited in Rabbits by Anti-Idiotype Monoclonal Antibodies Mimicking the CD4-Binding Site. PLoS ONE 3:10, pages e3423.
Crossref
Crossref
Xueling Wu, Anna Sambor, Martha C. Nason, Zhi-Yong Yang, Lan Wu, Susan Zolla-Pazner, Gary J. Nabel & John R. Mascola. (2008) Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference viruses. Virology 380:2, pages 285-295.
Crossref
Crossref
Kaboutar Babaahmady, Lesley A Bergmeier & Thomas Lehner. (2008) Combining human antisera to human leukocyte antigens, HIVgp120 and 70 kDa heat shock protein results in broadly neutralizing activity to HIV-1. AIDS 22:11, pages 1267-1276.
Crossref
Crossref
Barton F. Haynes & Robin J. Shattock. (2008) Critical issues in mucosal immunity for HIV-1 vaccine development. Journal of Allergy and Clinical Immunology 122:1, pages 3-9.
Crossref
Crossref
Patricia M. Day, Ratish Gambhira, Richard B. S. Roden, Douglas R. Lowy & John T. Schiller. (2008) Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific Antibodies. Journal of Virology 82:9, pages 4638-4646.
Crossref
Crossref
Eden P. Go, Janet Irungu, Ying Zhang, Dilusha S. Dalpathado, Hua-Xin Liao, Laura L. Sutherland, S. Munir Alam, Barton F. Haynes & Heather Desaire. (2008) Glycosylation Site-Specific Analysis of HIV Envelope Proteins (JR-FL and CON-S) Reveals Major Differences in Glycosylation Site Occupancy, Glycoform Profiles, and Antigenic Epitopesʼ Accessibility. Journal of Proteome Research 7:4, pages 1660-1674.
Crossref
Crossref
Alexandra Trkola, Herbert Kuster, Peter Rusert, Viktor von Wyl, Christine Leemann, Rainer Weber, Gabriela Stiegler, Hermann Katinger, Beda Joos & Huldrych F. Günthard. (2008) In Vivo Efficacy of Human Immunodeficiency Virus Neutralizing Antibodies: Estimates for Protective Titers. Journal of Virology 82:3, pages 1591-1599.
Crossref
Crossref
Dominique Beels, Leo Heyndrickx, Katleen Vereecken, Tine Vermoesen, Lieve Michiels, Guido Vanham & Luc Kestens. (2008) Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes. Journal of Virological Methods 147:1, pages 99-107.
Crossref
Crossref
Barton F. Haynes & S. Munir Alam. (2008) HIV-1 Hides an Achilles' Heel in Virion Lipids. Immunity 28:1, pages 10-12.
Crossref
Crossref
Qifeng Zhou, Rachmat Hidajat, Bo Peng, David Venzon, M. Kristine Aldrich, Ersell Richardson, Eun Mi Lee, V.S. Kalyanaraman, George Grimes, V. Ra?l G?mez-Rom?n, L. Ebonita Summers, Nina Malkevich & Marjorie Robert-Guroff. (2007) Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIVmac251. Vaccine 25:47, pages 8021-8035.
Crossref
Crossref
Stefan Baral, Susan G Sherman, Peggy Millson & Chris Beyrer. (2007) Vaccine immunogenicity in injecting drug users: a systematic review. The Lancet Infectious Diseases 7:10, pages 667-674.
Crossref
Crossref
Yuxing Li, Stephen A Migueles, Brent Welcher, Krisha Svehla, Adhuna Phogat, Mark K Louder, Xueling Wu, George M Shaw, Mark Connors, Richard T Wyatt & John R Mascola. (2007) Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nature Medicine 13:9, pages 1032-1034.
Crossref
Crossref
John R. Mascola. (2007) Allied responses. Nature 449:7158, pages 29-30.
Crossref
Crossref
Ralph Pantophlet, Rowena O. Aguilar-Sino, Terri Wrin, Lisa A. Cavacini & Dennis R. Burton. (2007) Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis. Virology 364:2, pages 441-453.
Crossref
Crossref
Viswanathan Lakshmanan, Galit Alter, Marcus Altfeld & Nina Bhardwaj. (2007) Biology of plasmacytoid dendritic cells and natural killer cells in HIV-1 infection. Current Opinion in HIV and AIDS 2:3, pages 189-200.
Crossref
Crossref